Lung Cancer Biomarkers — Patient Guide | XpertPatient Home › Biomarkers › Lung Cancer Biomarkers Biomarker Resource Center Lung Cancer Biomarkers Reviewed by XpertPatient Medical Advisory · Updated October 2026 · Primary Source: cancer.gov What Is a Biomarker — and Why Does It Matter for Your Treatment? A biomarker in lung cancer is a gene… Continue reading Lung Cancer Biomarkers
Tag: lung cancer
Lung Cancer Non Small Cell Stage 4 C-MET
Now that your doctors have identified your lung cancer as C-MET lung cancer, its time to compare the most common C-MET Lung Cancer Treatment options below. Familiarize yourself with the common Stage 4 C-MET non-small cell lung cancer treatment options below and then click Create My Conversation Guide to prepare a list of questions to… Continue reading Lung Cancer Non Small Cell Stage 4 C-MET
Lung Cancer Non-Small Cell Stage 4 HER2+
Now that your doctors have identified your lung cancer as HER2-positive lung cancer, its time to compare the most common HER2-positive Lung Cancer Treatment options below. Familiarize yourself with the common Stage 4 HER2+ non-small cell lung cancer treatment options below and then click Create My Conversation Guide to prepare a list of questions to… Continue reading Lung Cancer Non-Small Cell Stage 4 HER2+
Lung Cancer Non Small Cell Stage 4
Lung Cancer Non Small Cell Stage 3
Lung Cancer Non Small Cell Stage 2
Lung Cancer Non Small Cell Stage 1
Lung Cancer Small Cell Extensive Disease
Lung Cancer Small Cell Limited Disease
Lung Cancer Non Small Cell Stage 4 KRAS+
Stage 4 Non-Small Cell Lung Cancer (NSCLC) KRAS+ treatments vary by the organs affected by cancer. At Stage 4, the lung cancer has spread beyond your lungs, to other parts of your body like your bones, brain or liver. Take time to get familiar with the latest Stage 4 KRAS+ non-small cell lung cancer treatment options below.
